The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
10X Genomics, Inc. | COM CL A | 88025U109 | 21,800 | 481,770 | SH | SOLE | 481,770 | 0 | 0 | ||
908 DEVICES INC | COM | 65443P102 | 6,721 | 326,427 | SH | SOLE | 326,427 | 0 | 0 | ||
ABSCI CORP. | COM | 00091E109 | 192 | 57,804 | SH | SOLE | 57,804 | 0 | 0 | ||
ACUMEN PHARMACEUTICALS, INC | COM | 00509G209 | 16,060 | 3,417,075 | SH | SOLE | 3,417,075 | 0 | 0 | ||
CANDEL THERAPEUTICS, INC | COM | 137404109 | 2,630 | 811,737 | SH | SOLE | 811,737 | 0 | 0 | ||
CINCOR PHARMA, INC. | COM | 17240Y109 | 17,898 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
DICE THERAPEUTICS, INC. | COM | 23345J104 | 48,872 | 3,148,970 | SH | SOLE | 3,148,970 | 0 | 0 | ||
KARUNA THERAPEUTICS, INC. | COM | 48576A100 | 21,873 | 172,895 | SH | SOLE | 172,895 | 0 | 0 | ||
OLINK HOLDING AB | COM | 680710100 | 10,724 | 705,514 | SH | SOLE | 705,514 | 0 | 0 | ||
REPLIGEN CORP. | COM | 759916109 | 3,661 | 22,544 | SH | SOLE | 22,544 | 0 | 0 | ||
SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,369 | 787,007 | SH | SOLE | 787,007 | 0 | 0 | ||
TARSUS PHARMACEUTICALS INC | COM | 87650L103 | 3,796 | 260,000 | SH | SOLE | 260,000 | 0 | 0 | ||
TAYSHA GENE THERAPIES INC | COM | 877619106 | 2,697 | 724,873 | SH | SOLE | 724,873 | 0 | 0 | ||
DOORDASH INC | COM CL A | 25809K105 | 38,595 | 601,454 | SH | SOLE | 601,454 | 0 | 0 | ||
NU HOLDINGS LTD. | COM CL A | G6683N103 | 34,172 | 9,136,835 | SH | SOLE | 9,136,835 | 0 | 0 | ||
SAMSARA, INC. | COM CL A | 79589L106 | 3,641 | 326,000 | SH | SOLE | 326,000 | 0 | 0 | ||
SAMSARA, INC. | COM CL B | FDS1Q2O30 | 30,296 | 2,712,256 | SH | SOLE | 27,122,560 | 0 | 0 | ||
SNOWFLAKE INC | COM CL A | 833445109 | 29,845 | 214,621 | SH | SOLE | 214,621 | 0 | 0 | ||
UIPATH INC | COM CL A | 90364P105 | 69,336 | 3,811,779 | SH | SOLE | 3,811,779 | 0 | 0 |